Nabipur L, Mouawad M, Venketaraman V
Biomedicines. 2025; 13(2).
PMID: 40002814
PMC: 11852381.
DOI: 10.3390/biomedicines13020401.
Zielinska M, Ciazynska M, Sulejczak D, Rutkowski P, Czarnecka A
Biomolecules. 2025; 15(2).
PMID: 40001572
PMC: 11853485.
DOI: 10.3390/biom15020269.
Cammarota A, Woodford R, Smyth E
Drugs. 2025; 85(3):361-383.
PMID: 39843758
DOI: 10.1007/s40265-024-02132-2.
Jin J, Li Y, Liu X, Yan C, Cheng Z, Wu Y
Mar Biotechnol (NY). 2025; 27(1):33.
PMID: 39833483
DOI: 10.1007/s10126-025-10413-4.
Katsuki S, Minami K, Oniwa K, Yagi M, Shimizu S, Hamatani N
J Radiat Res. 2024; 66(1):97-102.
PMID: 39724928
PMC: 11753840.
DOI: 10.1093/jrr/rrae091.
Fc Effector Function of Immune Checkpoint Blocking Antibodies in Oncology.
Martineau R, Susini S, Marabelle A
Immunol Rev. 2024; 328(1):334-349.
PMID: 39663733
PMC: 11659940.
DOI: 10.1111/imr.13427.
Changes in tumor and cardiac metabolism upon immune checkpoint.
Leven A, Wagner N, Nienaber S, Messiha D, Tasdogan A, Ugurel S
Basic Res Cardiol. 2024; 120(1):133-152.
PMID: 39658699
PMC: 11790718.
DOI: 10.1007/s00395-024-01092-8.
Common biological processes and mutual crosstalk mechanisms between cardiovascular disease and cancer.
Gao H, Chen Z, Yao Y, He Y, Hu X
Front Oncol. 2024; 14:1453090.
PMID: 39634266
PMC: 11614734.
DOI: 10.3389/fonc.2024.1453090.
Research progress of CD80 in the development of immunotherapy drugs.
Li L, Yang L, Jiang D
Front Immunol. 2024; 15:1496992.
PMID: 39575257
PMC: 11578925.
DOI: 10.3389/fimmu.2024.1496992.
Cancer Biomarkers and Precision Oncology: A Review of Recent Trends and Innovations.
Aldoughaim M, Alsuhebany N, Alzahrani M, Alqahtani T, Alghamdi S, Badreldin H
Clin Med Insights Oncol. 2024; 18:11795549241298541.
PMID: 39559827
PMC: 11571259.
DOI: 10.1177/11795549241298541.
In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy.
Mao C, Deng F, Zhu W, Xie L, Wang Y, Li G
Nat Commun. 2024; 15(1):9723.
PMID: 39521768
PMC: 11550832.
DOI: 10.1038/s41467-024-54081-9.
Innovative theranostic hydrogels for targeted gastrointestinal cancer treatment.
Tang M, Song J, Zhang S, Shu X, Liu S, Ashrafizadeh M
J Transl Med. 2024; 22(1):970.
PMID: 39465365
PMC: 11514878.
DOI: 10.1186/s12967-024-05749-9.
Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia.
Cao H, Xiao J, Baylink D, Nguyen V, Shim N, Lee J
Biomedicines. 2024; 12(10).
PMID: 39457563
PMC: 11504511.
DOI: 10.3390/biomedicines12102250.
The prognostic factors of clinical outcomes in non-small cell lung cancer patients receiving subsequent treatments after progression on initial immunotherapy.
Fu S, Lu Z, Wei S, Chen Z, Tang J, Wang J
J Thorac Dis. 2024; 16(9):6012-6023.
PMID: 39444890
PMC: 11494584.
DOI: 10.21037/jtd-24-57.
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?.
Du R, Zhang J, Lukas R, Tripathi S, Ahrendsen J, Curran M
Neuro Oncol. 2024; 27(1):33-49.
PMID: 39427326
PMC: 11726257.
DOI: 10.1093/neuonc/noae193.
Therapeutic implications for the PD-1 axis in cerebrovascular injury.
Feghali J, Jackson C
Neurotherapeutics. 2024; 22(1):e00459.
PMID: 39368872
PMC: 11840351.
DOI: 10.1016/j.neurot.2024.e00459.
Preclinical antibody-PET imaging of PD-L1.
Brown E, DeWeerd R, Zidel A, Pereira P
Front Nucl Med. 2024; 2:953202.
PMID: 39354977
PMC: 11440863.
DOI: 10.3389/fnume.2022.953202.
The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC.
Huang H, Huang Y, Chen Y, Wu H, Hsu C, Kao H
Oncogenesis. 2024; 13(1):36.
PMID: 39353912
PMC: 11445275.
DOI: 10.1038/s41389-024-00532-3.
Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche.
Khattab S, El Sorady M, El-Ghandour A, Visani G, Piccaluga P
Explor Target Antitumor Ther. 2024; 5(5):1027-1055.
PMID: 39351440
PMC: 11438561.
DOI: 10.37349/etat.2024.00262.
Quiescence and aging of melanocyte stem cells and a novel association with programmed death-ligand 1.
Palmer J, Villavicencio K, Idris M, Baranyk I, Polycarp N, Dawson A
iScience. 2024; 27(10):110908.
PMID: 39351197
PMC: 11440800.
DOI: 10.1016/j.isci.2024.110908.